After completing pre-clinical studies on its new Zika vaccine candidate Zikavac, Hyderabad, India-based Bharat Biotech announced that the company is now seeking the approval of the government to begin Phase-1 trials where the inactivated vaccine candidate will be tested on 100 people, reports BioSpectrum. India has no known cases of...